Facilitating Access to Information on Human Proteins and Their Phosphorylation

促进获取有关人类蛋白质及其磷酸化的信息

基本信息

  • 批准号:
    7732981
  • 负责人:
  • 金额:
    $ 17.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

As anticipated in last years annual report the MPR web site http://mpr.nci.nih.gov/ has undergone a major multi-component improvement in infrastructure this year. The most fundamental change is from the Microsoft .NET framework to Ruby on Rails (ROR). The rationale was that the proprietary.NET architecture has not evolved to be nearly as efficient in implementation or alteration as was widely anticipated. In contrast, ROR is a very powerful, open-source framework for developing database-backed web applications. The emerging evidence indicated to us that ROR was on a trajectory similar to that of Linux in its early days, and was becoming the framework of choice for database driven web applications like MPR. This rewrite provided the opportunity to incorporate enhancements. For example: 1) in MPR.ROR literature citations are displayed in each context where a phosphorylation site is shown, rather than in a few selected contexts in MRP.NET; 2) An enhanced search for molecules is incorporated; and 3) Internal data retrieval is based on simpler, more robust query strategies. In concert with the rewrite, hosting has been moved entirely to NCI Servers to assure reliability. A big part of this effort was working with staff (employees and contractors) of NCIWeb to introduce this new technology to NCIWeb. While there was a wealth of documentation for Ruby on Rails deployment, very little pertained to NCIWEB configurations. Thus, significant adaptations were required. In addition, systems security has been markedly improved, facilitated by security scans and technology in place on the NCI servers. The new MPR.ROR is being deployed in early October 2008. Concurrent with these changes, content has been culled of antibodies withdrawn from the market, and augmented by new antibodies from 7 companies. Several of the companies with the largest numbers of antibodies have purchased by larger vendors. The required URLs and identifier changes have been implemented to maintain direct linkage of the antibodies to the primary data from the suppliers. Background on Ruby on Rails http://rubythis.blogspot.com/2006/12/justify-your-choice-of-ruby-on-rails.html http://www.oracle.com/technology/pub/articles/haefel-oracle-ruby.html

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Shaw其他文献

James Shaw的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Shaw', 18)}}的其他基金

Facilitating Access to Information on Human Proteins and
促进获取有关人类蛋白质和
  • 批准号:
    7291810
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular architecture of lymphocyte cortex
淋巴细胞皮层的分子结构
  • 批准号:
    7965913
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular mechanisms of ERM regulation
ERM调节的分子机制
  • 批准号:
    7965921
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Facilitating Access to Information on Human Proteins and Their Phosphorylation
促进获取有关人类蛋白质及其磷酸化的信息
  • 批准号:
    7965216
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular mechanisms of ERM regulation
ERM调节的分子机制
  • 批准号:
    7733400
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Mechanisms of Cellular Immune Responses
细胞免疫反应的机制
  • 批准号:
    8552612
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular mechanisms of ERM regulation
ERM调节的分子机制
  • 批准号:
    8552921
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Mechanisms of Cellular Immune Responses
细胞免疫反应的机制
  • 批准号:
    6762141
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular architecture of lymphocyte cortex
淋巴细胞皮层的分子结构
  • 批准号:
    7733397
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:
Facilitating Access to Information on Human Proteins and Their Phosphorylation
促进获取有关人类蛋白质及其磷酸化的信息
  • 批准号:
    7592641
  • 财政年份:
  • 资助金额:
    $ 17.26万
  • 项目类别:

相似海外基金

Administrative Core
行政核心
  • 批准号:
    10549641
  • 财政年份:
    2023
  • 资助金额:
    $ 17.26万
  • 项目类别:
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
  • 批准号:
    10760626
  • 财政年份:
    2023
  • 资助金额:
    $ 17.26万
  • 项目类别:
IgE Suppressing Berberine Nanomedicine for Treatment of Food Allergies
抑制 IgE 的小檗碱纳米药物治疗食物过敏
  • 批准号:
    10698900
  • 财政年份:
    2023
  • 资助金额:
    $ 17.26万
  • 项目类别:
Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis
鉴定杀菌抗体特异性,用于开发针对脑膜炎奈瑟菌的新型广泛覆盖候选疫苗
  • 批准号:
    10404598
  • 财政年份:
    2021
  • 资助金额:
    $ 17.26万
  • 项目类别:
Molecular basis of immunity to tick-borne rickettsioses
蜱传立克次体病免疫的分子基础
  • 批准号:
    10673274
  • 财政年份:
    2021
  • 资助金额:
    $ 17.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了